Separable pathway effects of semi-competing risks using multi-state models (2306.15947v3)
Abstract: Semi-competing risks refer to the phenomenon where a primary event (such as mortality) can ``censor'' an intermediate event (such as relapse of a disease), but not vice versa. Under the multi-state model, the primary event consists of two specific types: the direct outcome event and an indirect outcome event developed from intermediate events. Within this framework, we show that the total treatment effect on the cumulative incidence of the primary event can be decomposed into three separable pathway effects, capturing treatment effects on population-level transition rates between states. We next propose two estimators for the counterfactual cumulative incidences of the primary event under hypothetical treatment components. One estimator is given by the generalized Nelson--Aalen estimator with inverse probability weighting under covariates isolation, and the other is given based on the efficient influence function. The asymptotic normality of these estimators is established. The first estimator only involves a propensity score model and avoid modeling the cause-specific hazards. The second estimator has robustness against the misspecification of submodels. As an illustration of its potential usefulness, the proposed method is applied to compare effects of different allogeneic stem cell transplantation types on overall survival after transplantation.
- Does Cox analysis of a randomized survival study yield a causal treatment effect? Lifetime Data Analysis, 21(4):579–593.
- The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6):1173.
- Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: A retrospective and prospective analysis. Journal of Hematology & Oncology, 10(1):1–13.
- Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: A phase 3 genetically randomized study. Journal of Hematology & Oncology, 13(1):1–13.
- Bias by censoring for competing events in survival analysis. BMJ, 378:e071349.
- Didelez, V. (2019). Defining causal mediation with a longitudinal mediator and a survival outcome. Lifetime data analysis, 25:593–610.
- On semi-competing risks data. Biometrika, 88(4):907–919.
- Principal stratification in causal inference. Biometrics, 58(1):21–29.
- Defining and estimating subgroup mediation effects with semi-competing risks data. Statistica Sinica.
- Shared frailty methods for complex survival data: A review of recent advances. Annual Review of Statistics and Its Application, 10(1):51–73.
- A weighted risk set estimator for survival distributions in two-stage randomization designs with censored survival data. International Journal of Biostatistics, 1(1):1–17.
- Semi-competing risks data analysis: Accounting for death as a competing risk when the outcome of interest is nonterminal. Circulation: Cardiovascular Quality and Outcomes, 9(3):322–331.
- Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults. Biology of Blood and Marrow Transplantation, 25(8):1597–1602.
- Efficient estimation of average treatment effects using the estimated propensity score. Econometrica, 71(4):1161–1189.
- Huang, Y.-T. (2021). Causal mediation of semicompeting risks. Biometrics, 77(4):1143–1154.
- Huang, Y.-T. (2022). Hypothesis test for causal mediation of time-to-event mediator and outcome. Statistics in Medicine, 41(11):1971–1985.
- The statistical analysis of failure time data. John Wiley & Sons.
- Modern approaches to hla-haploidentical blood or marrow transplantation. Nature Reviews Clinical Oncology, 13(1):10–24.
- Direct and indirect effects in a survival context. Epidemiology, 22(4):575–581.
- Estimation of separable direct and indirect effects in continuous time. Biometrics, 79(1):127–139.
- On collapsibility and confounding bias in Cox and Aalen regression models. Lifetime Data Analysis, 19(3):279–296.
- Estimation of direct effects for survival data by using the Aalen additive hazards model. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 73(5):773–788.
- Causal inference for semi-competing risks data. Biostatistics, 23(4):1115–1132.
- Single world intervention graphs (swigs): A unification of the counterfactual and graphical approaches to causality. Center for the Statistics and the Social Sciences, University of Washington Series. Working Paper, 128(30):2013.
- Robins, J. M. (1997). Causal inference from complex longitudinal data. In Latent Variable Modeling and Applications to Causality, pages 69–117. Springer.
- Alternative graphical causal models and the identification of direct effects. Causality and psychopathology: Finding the determinants of disorders and their cures, 84:103–158.
- Rubin, D. B. (2006). Causal inference through potential outcomes and principal stratification: Application to studies with “censoring” due to death. Statistical Science, 21(3):299–309.
- A generalized theory of separable effects in competing event settings. Lifetime Data Analysis, 27(4):588–631.
- Separable effects for causal inference in the presence of competing events. Journal of the American Statistical Association, 117(537):175–183.
- Tchetgen Tchetgen, E. J. (2011). On causal mediation analysis with a survival outcome. The International Journal of Biostatistics, 7(1).
- Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confounding. Statistics in Medicine, 38(24):4828–4840.
- Adjusted nelson–aalen estimates with retrospective matching. Journal of the American Statistical Association, 97(457):245–256.
- Statistical analysis of illness–death processes and semicompeting risks data. Biometrics, 66(3):716–725.
- A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks. Biostatistics, 23(1):34–49.
- Using post-outcome measurement information in censoring-by-death problems. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 78(1):299–318.
- A causal framework for classical statistical estimands in failure-time settings with competing events. Statistics in Medicine, 39(8):1199–1236.
- Marginal structural illness-death models for semi-competing risks data. arXiv preprint arXiv:2204.10426.
- Causal mediation analysis on failure time outcome without sequential ignorability. Lifetime Data Analysis, 23:533–559.